Greenwich Biosciences, Inc. is the US subsidiary of GW Pharmaceuticals plc. For general corporate information, please click here.
Exciting things are happening at Greenwich Biosciences. Here is the latest news about our company, products, and pipeline.
Greenwich Biosciences, Inc. is the US subsidiary of GW Pharmaceuticals plc. For general corporate information, please click here.
For investor inquiries and media, please contact:
Stephen Schultz
Vice President, Investor Relations
917.280.2424 Tel.
760.795.2219 Fax
Email
Christy Curran
Sam Brown Inc.
615-414-8668 Tel.
Email
You are leaving the website of Greenwich Biosciences, Inc., the US subsidiary of GW Pharmaceuticals plc. This link will take you to a website to which our Privacy Policy does not apply.
We are closely monitoring our supply chain of EPIDIOLEX® (cannabidiol) and, at this time, do not foresee any supply interruptions in the United States.
At Greenwich Biosciences, our main concern is the well-being of our patients, healthcare partners, and employees. Our hearts and thoughts go out to the people who have been affected. We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent.